Allogene Therapeutics, Inc 10-K for FY2023
Allogene Therapeutics, Inc. (ALLO)
10-K
2024-03-14
For: 2023-12-31
View Original
Added on
April 06, 2026
About this 10-K
Allogene Therapeutics, Inc filed this 10-K on March 14, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $95K
- down 39.1% from $156K a year earlier
- Net loss
- $327.27M
- compared with a net loss of $340.41M a year earlier
- Diluted EPS
- -$2.09
- compared with -$2.38 a year earlier